In today’s briefing:
- India EdTech Woes: Waning Demand, Dried up Funding & Risk of Eroding Valuations
- Mankind Pharma Pre-IPO Tearsheet
- Trimble Inc: Detailed Credit Analysis & Financial Strength Evaluation Report
- EbixCash Pre-IPO – The Positives – The Few that There Are: Diversified Offering, Fast Revenue Growth
India EdTech Woes: Waning Demand, Dried up Funding & Risk of Eroding Valuations
- BYJU’S (1391510D IN), the world’s most valued online learning company, shocked the street with reported losses of USD576 mn on revenues of USD286 mn for the year ending March2021.
- Post-Pandemic return to school has reset growth trajectory for India’s blooming EdTech sector that thrived during COVID times attracting multi-billion dollar valuations.
- Industry wide layoffs and few shut downs have raised concerns on growth prospects for edTech players and sustainability of their boom period valuations.
Mankind Pharma Pre-IPO Tearsheet
- Mankind Pharma Ltd (6596876Z IN) is looking to raise about US$1bn in its upcoming India IPO. The deal will be run by Kotak, Axis Capital, IIFL Securities, Jefferies and JPM.
- Mankind Pharma (MK) is a pharmaceutical company engaged in developing, manufacturing and marketing a range of pharmaceutical formulations across various therapeutic areas, as well as several consumer healthcare products.
- It is mainly focused on the domestic market. 18 of its brands were among the 300 highest selling brands in the Indian Pharmaceutical Market (IPM), according to IQVIA.
Trimble Inc: Detailed Credit Analysis & Financial Strength Evaluation Report
- Trimble Inc is a well-known player in the agri-tech space.
- The company has gone through its fair share of corporate restructuring with a series of acquisitions and divestments.
- On execution, Trimble continues to simplify its portfolio through actions like decreasing the number of product offerings and part numbers.
EbixCash Pre-IPO – The Positives – The Few that There Are: Diversified Offering, Fast Revenue Growth
- EbixCash (EC) is looking to raise around US$800m in its upcoming India IPO. The deal will be run by Motilal, Equirus, ISec, SBI Caps and Yes Securities.
- EC is a provider of digital products and services in the B2C, B2B and financial technology arena. Its has four primary business segments: Payment solutions, travel, financial technologies and BPO.
- In this note, we talk about the positive aspects of the deal.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
